(Report ID: 60078) Drug interactions analysis of: Oxycontin, Oxycodone Hcl, Relafen, Wellbutrin, Altace, Protonix, Elavil, Atenolol, Zoloft, Cenestin, Mavik, Ortho-est, Miacalcin, Hydrochlorothiazide, Vitamin E, Calcium Gluconate, Ritalin, Ferrous Sulfate Tab, Azmacort, ActonelMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 19, 2008, eHealthMe analyzes 10,180,564 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 19, 2008: 4 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 60078 | Feb, 22, 2006 | 63 | Female |
List of drugs the patient takes:
| Drug |
Oxycontin |
Oxycodone Hcl |
Relafen |
Wellbutrin |
Altace |
Protonix |
Elavil |
Atenolol |
Zoloft |
Cenestin |
Mavik |
Ortho-est |
Miacalcin |
Hydrochlorothiazide |
Vitamin E |
Calcium Gluconate |
Ritalin |
Ferrous Sulfate Tab |
Azmacort |
Actonel |
List of drug interactions, adverse side effects / events the patient has:
| Name |
Abdominal Pain Upper |
Ascites |
Asthenia |
Back Pain |
Breast Mass |
Bronchitis |
Buttock Pain |
Candidiasis |
Cerumen Impaction |
Cognitive Disorder |
Condition Aggravated |
Depression |
Drug Dependence |
Drug Withdrawal Syndrome |
Gastrointestinal Disorder |
Hepatic Steatosis |
Hypokalaemia |
Hypotension |
Inappropriate Schedule Of Drug Administration |
Increased Upper Airway Secretion |
Iron Deficiency Anaemia |
Leukocytosis |
Liver Abscess |
Migraine |
Muscle Tightness |
Musculoskeletal Stiffness |
Nasal Congestion |
Obsessive-compulsive Disorder |
Pain In Extremity |
Pancreatitis Acute |
Panic Disorder |
Paranoia |
Parotid Gland Enlargement |
Pharyngolaryngeal Pain |
Pneumonia Klebsiella |
Pyrexia |
Restlessness |
Rhinitis |
Sedation |
Shoulder Pain |
Sinus Operation |
Sinusitis |
Stomatitis |
Results from eHealthMe: 4 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Abdominal Pain Upper | 2 (50.00%) |
Ascites | 4 (100.00%) |
Asthenia | 2 (50.00%) |
Back Pain | 4 (100.00%) |
Breast Mass | 4 (100.00%) |
Bronchitis | 4 (100.00%) |
Buttock Pain | 4 (100.00%) |
Candidiasis | 4 (100.00%) |
Cerumen Impaction | 4 (100.00%) |
Cognitive Disorder | 2 (50.00%) |
Condition Aggravated | 1 (25.00%) |
Depression | 4 (100.00%) |
Drug Dependence | 4 (100.00%) |
Drug Withdrawal Syndrome | 4 (100.00%) |
Gastrointestinal Disorder | 2 (50.00%) |
Hepatic Steatosis | 4 (100.00%) |
Hypokalaemia | 4 (100.00%) |
Hypotension | 2 (50.00%) |
Inappropriate Schedule Of Drug Administration | 3 (75.00%) |
Increased Upper Airway Secretion | 3 (75.00%) |
Iron Deficiency Anaemia | 2 (50.00%) |
Leukocytosis | 4 (100.00%) |
Liver Abscess | 2 (50.00%) |
Migraine | 4 (100.00%) |
Muscle Tightness | 1 (25.00%) |
Musculoskeletal Stiffness | 1 (25.00%) |
Nasal Congestion | 2 (50.00%) |
Obsessive-compulsive Disorder | 4 (100.00%) |
Pain In Extremity | 4 (100.00%) |
Pancreatitis Acute | 4 (100.00%) |
Panic Disorder | 2 (50.00%) |
Paranoia | 4 (100.00%) |
Parotid Gland Enlargement | 4 (100.00%) |
Pharyngolaryngeal Pain | 4 (100.00%) |
Pneumonia Klebsiella | 2 (50.00%) |
Pyrexia | 3 (75.00%) |
Restlessness | 2 (50.00%) |
Rhinitis | 2 (50.00%) |
Sedation | 2 (50.00%) |
Shoulder Pain | 3 (75.00%) |
Sinus Operation | 1 (25.00%) |
Sinusitis | 4 (100.00%) |
Stomatitis | 4 (100.00%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:
3) Top co-used drugs drugs reported for the past 12 months:
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Sinusitis | 4 (100.00%) |
2 | Leukocytosis | 4 (100.00%) |
3 | Pharyngolaryngeal Pain | 4 (100.00%) |
4 | Hepatic Steatosis | 4 (100.00%) |
5 | Stomatitis | 4 (100.00%) |
6 | Migraine | 4 (100.00%) |
7 | Obsessive-compulsive Disorder | 4 (100.00%) |
8 | Parotid Gland Enlargement | 4 (100.00%) |
9 | Paranoia | 4 (100.00%) |
10 | Pancreatitis Acute | 4 (100.00%) |
5) Top co-used drugs drugs reported of all time:
| Name | Count |
1 | Potassium Chloride | 1 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Side effects comparison of Zetia (Msp Singapore) - 10MG (Nov, 19, 2008)
|
Ramipril 10 MG for Blood Pressure (Nov, 19, 2008)
|
Wellbutrin Sr (Glaxosmithkline) - 150MG for Depression (Nov, 19, 2008)
|
Bupropion Hydrochloride (Sandoz) - 10... for Depression (Nov, 19, 2008)
|
Albuterol (Armstrong Pharms) - 0.09MG... for Asthma (Nov, 19, 2008)
|
Albuterol for Asthma (Nov, 19, 2008)
|
Digoxin for Atrial Fibrillation/flutter (Nov, 19, 2008)
|
Atenolol for Tachycardia (Nov, 19, 2008)
|
Gabapentin (Actavis Elizabeth) - 300MG for Neuritis - Peripheral (Nov, 19, 2008)
|
Abilify (Otsuka) - 5MG for Bi Polar (Nov, 19, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|